Floatz logo

889 assets in Neoplasm

Therapeutic assets addressing Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cpg-Odn
Neoplasm
Second Affiliated Hospital of Guangzhou Medical UniversityP1C (36)
Cusp06
Neoplasm
OnCusp Therapeutics, Inc.P1C (36)
Dfp-14927
Neoplasm
Delta-Fly Pharma, Inc.P1C (36)
dk210
Neoplasm
DEKA BiosciencesP1C (36)
dr30206
Neoplasm
Zhejiang Doer Biologics Co., Ltd.P1C (36)
Drug: Ibi3028
Neoplasm
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.P1C (36)
ds-1055a
Neoplasm
Daiichi SankyoP1C (36)
Dxp-106
Neoplasm
Singlomics Biopharmaceuticals Zhuhai Co., Ltd.P1C (36)
Ecp-1014
Neoplasm
Euclises Pharmaceuticals, Inc.P1C (36)
Enoblituzumab
Neoplasm
Masonic Cancer Center, University of MinnesotaP1C (36)
es014
Neoplasm
Elpiscience (Suzhou) Biopharma, Ltd.P1C (36)
eu103
Neoplasm
EutilexP1C (36)
exs74539
Neoplasm
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1C (36)
Fcn-098
Neoplasm
Fochon Pharmaceuticals, Ltd.P1C (36)
ftl001
Neoplasm
Sound Biopharmaceuticals Ltd.P1C (36)
Gnc-035
Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.P1C (36)
Gnc-039
Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.P1C (36)
Gnc-077
Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.P1C (36)
gs-4528
Neoplasm
Gilead SciencesP1C (36)
gt201
Neoplasm
RenJi HospitalP1/2C (36)
Gtb-5550
Neoplasm
Masonic Cancer Center, University of MinnesotaP1C (36)
Hbi-2376
Neoplasm
HUYABIO International, LLC.P1C (36)
Hbi-2438
Neoplasm
HUYABIO International, LLC.P1C (36)
hdm2020
Neoplasm
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.P1C (36)
Hemay181
Neoplasm
Ganzhou Hemay Pharmaceutical Co., LtdP1C (36)
hg146
Neoplasm
HitGen Inc.P1C (36)
hh160
Neoplasm
Huahui HealthP1C (36)
Hlx 208
Neoplasm
Shanghai Henlius BiotechP1C (36)
Hpv-T
Neoplasm
BGI, ChinaP1C (36)
hs-20117
Neoplasm
Hansoh BioMedical R&D CompanyP1C (36)
Hs-It101
Neoplasm
Qingdao Sino-Cell Biomedicine Co., Ltd.P1C (36)
Humanized Immunoglobulin G1-Kappa Anti-(Human Cd8) Fused At The C-Terminus Of One Heavy Chain, Via Peptide Linker <Sup>449</Sup> Sggggsggggsggggs<Sup>464</Sup>, To A Variant Of Human Interleukin-2, Glycoform Alfa
Neoplasm
Asher Biotherapeutics, Inc.P1C (36)
il-12
Neoplasm
Memorial Sloan Kettering Cancer CenterP1C (36)
Imgs-001
Neoplasm
ImmunoGenesisP1C (36)
Imiquimod
Neoplasm
Toray Industries, IncP1C (36)
Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer
Neoplasm
Tianjin Medical University Second HospitalP1C (36)
Immunoglobulin G1, Anti-(Human Sialic Acid-Binding Ig-Like Lectin 15) (Human Monoclonal Pyx-106 ?1-Chain), Disulfide With Human Monoclonal Pyx-106 ?-Chain, Dimer
Neoplasm
Pyxis Oncology, IncP1C (36)
Immunoglobulin G4(228-Proline), Anti-(Human Cd47 Antigen) (Human Monoclonal Sti-6643 .Gamma.4-Chain), Disulfide With Human Monoclonal Sti-6643 .Kappa.-Chain, Dimer
Neoplasm
Sorrento Therapeutics, Inc.P1C (36)
inp12
Neoplasm
InnoUp Farma S.L.P1C (36)
Ivaltinostat
Neoplasm
Machaon Biotherapeutics, Inc.P1C (36)
Jbz-001
Neoplasm
Jabez Bioscience, IncP1C (36)
Jsi-1187
Neoplasm
JS InnoPharm, LLCP1C (36)
jyb1907
Neoplasm
JemincareP1C (36)
jzp815
Neoplasm
Jazz PharmaceuticalsP1C (36)
kd033
Neoplasm
Kadmon, a Sanofi CompanyP1C (36)
Lisaftoclax
Neoplasm
Ascentage Pharma Group Inc.P1C (36)
LY 3200882
Neoplasm
Eli Lilly and CompanyP1C (36)
m1-c6v1
Neoplasm
Guangzhou Virotech Pharmaceutical Co., Ltd.P1C (36)
MAT2A-IN-9
Neoplasm
IDEAYA BiosciencesP1C (36)
Max-10181
Neoplasm
Maxinovel Pty., Ltd.P1C (36)
Showing 701 to 750 of 889 assets
PreviousPage 15 of 18Next